Back to STATE STREET CORP STATE STREET CORP

TVTXTVTX
Showing 8 of 22 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in TRAVERE THERAPEUTICS INC

Yes. State Street holds 4,256,224 shares of TVTX (Travere Therapeutics), worth $241.8M, as of its Q2 2026 13F filing. It reduced the position by 703,764 shares (-14.2%) from Q1 2026. State Street has held TVTX since Q1 2021, across 22 quarterly 13F filings.

Current Value

$241.8M

Current Shares

4.3M

Total Value Change

+$203.5M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.3M
-14.2%
$241.8M0.0%$56.81
0
2026-Q1
Increased
5M
+4.3%
$147.4M0.0%$29.71
32
2025-Q4
Increased
4.8M
+47.8%
$181.8M0.0%$38.21
42
2025-Q3
Decreased
3.2M
-7.6%
$76.9M0.0%$23.90
0
2025-Q2
Decreased
3.5M
-4.5%
$51.6M0.0%$14.80
0
2025-Q1
Decreased
3.6M
-3.2%
$65.3M0.0%$17.92
0
2024-Q4
Increased
3.8M
+37.7%
$65.6M0.0%$17.42
39
2024-Q3
Decreased
2.7M
-22.1%
$38.3M0.0%$13.99
0

Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used